ReviewAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2020
Current and emerging treatments for chronic spontaneous urticaria.
Review in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 44 citations in OpenAlex.
- Emerging and Newly Approved Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Narrative Review.Diseases (Basel, Switzerland) · 2026Review
- Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study.Acta dermato-venereologica · 2026Observational
- Expanding treatment options in chronic spontaneous urticaria: the emerging role of dupilumab.Annals of medicine and surgery (2012) · 2026Article
- Elucidating the Mechanism of Xiaoqinglong Decoction in Chronic Urticaria Treatment: An Integrated Approach of Network Pharmacology, Bioinformatics Analysis, Molecular Docking, and Molecular Dynamics Simulations.Current computer-aided drug design · 2026Article
- History of cold urticaria research: from systematic studies of the 19th century to modern prospective strategies in clinical practice.Immunologic research · 2025Review
- Quantifying patient preferences for treatments for refractory chronic spontaneous urticaria.The journal of allergy and clinical immunology. Global · 2025Article
- Type 2 Inflammation and Its Role in Dermatologic Diseases.International journal of dermatology · 2025Review
- Sleep Disturbance and Chronic Urticaria: A Narrative Review of Its Relationship, Treatment and Evolving Literature.Health science reports · 2025Article
- Factors associated with quality of life of chronic spontaneous urticaria patients in a Vietnamese population.PloS one · 2025Article
- Biomarkers for Short-Term Omalizumab Response in Chronic Spontaneous Urticaria.Annals of dermatology · 2024Article
- Mapping the intellectual structure of the research of omalizumab in chronic spontaneous urticaria: A bibliometric analysis.The journal of allergy and clinical immunology. Global · 2024Article
- Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria.The World Allergy Organization journal · 2024Article
- Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review.Dermatology and therapy · 2023Review
- Acupuncture combined with pricking and cupping therapy is effective in patients with chronic spontaneous urticaria.American journal of translational research · 2023Article
- Novel MRGX2 Antagonists for Treating Diseases.ACS medicinal chemistry letters · 2022Article
- Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.Medicina (Kaunas, Lithuania) · 2022Review
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.Frontiers in medicine · 2022Review
- Review
- Chronic Urticaria in Children: an Update on Diagnosis and Treatment.Current allergy and asthma reports · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveTo review the published literature on current and new treatments for chronic spontaneous urticaria (CSU) and to provide guidance on the potential use of these therapeutics. DATA SOURCES: A PubMed search was performed to include English-language articles with the keywords chronic spontaneous urticaria, pathophysiology, quality of life, and treatments, with a preference to those articles written in the last 5 years. ClinicalTrials.gov was reviewed for recent relevant clinical trials related to potential CSU therapeutics. STUDY SELECTIONS: Literature was included if it provided information related to the current understanding of the pathophysiology and management of CSU as well as potential novel therapeutics currently in development.
resultsCSU has a significant effect on patients' quality of life. Current therapies include antihistamines, leukotriene receptor antagonists, omalizumab, and immunosuppressants; however, additional treatments are needed. New therapeutics under investigation include IgG1 anti-IgE monoclonal antibodies (ligelizumab), chemoattractant rector-homologous molecule expressed on T
conclusionThe development of new treatments for CSU will lead to improved options for patients and may assist with improving our understanding of disease pathophysiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.